[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Gut and liver, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence

R Nevola, R Ruocco, L Criscuolo, A Villani… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

AG Singal, JM Llovet, M Yarchoan, N Mehta… - Hepatology, 2023 - journals.lww.com
This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China

XF Xu, H Xing, J Han, ZL Li, WY Lau, YH Zhou… - JAMA …, 2019 - jamanetwork.com
Importance Late recurrence (more than 2 years) after liver resection for hepatocellular
carcinoma (HCC) is generally considered as a multicentric tumor or a de novo cancer …

[HTML][HTML] Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular …

HHM Ng, RY Lee, S Goh, ISY Tay, X Lim… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Methods Clinically annotated samples from 49 patients with advanced HCC treated with ICB
were analyzed for CD38 expression using immunohistochemistry (IHC), multiplex …

Early and late recurrence of hepatitis B virus‐associated hepatocellular carcinoma

MD Wang, C Li, L Liang, H Xing, LY Sun, B Quan… - The …, 2020 - academic.oup.com
Background Survival after liver resection of hepatocellular carcinoma (HCC) remains poor
because of a high incidence of recurrence. We sought to investigate risk factors, patterns …

Advances in resection and transplantation for hepatocellular carcinoma

E Vibert, M Schwartz, KM Olthoff - Journal of hepatology, 2020 - Elsevier
It would be impossible to summarise all of the significant developments in the surgical
management of hepatocellular carcinoma (HCC), even just over the past year, in a …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi …

LQ Yao, ZL Chen, ZH Feng, YK Diao, C Li… - Annals of surgical …, 2022 - Springer
Background A potentially curative hepatic resection is the optimal treatment for
hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur …

[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …